UnitedHealth Group (UNH) to Release Quarterly Earnings on Tuesday

UnitedHealth Group (NYSE:UNH) is set to announce its earnings results before the market opens on Tuesday, October 15th. Analysts expect the company to announce earnings of $7.05 per share for the quarter. UnitedHealth Group has set its FY 2024 guidance at 27.500-28.000 EPS and its FY24 guidance at $27.50-28.00 EPS.Investors that wish to listen to the company’s conference call can do so using this link.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. The company had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period in the previous year, the business posted $6.14 EPS. On average, analysts expect UnitedHealth Group to post $28 EPS for the current fiscal year and $31 EPS for the next fiscal year.

UnitedHealth Group Trading Down 1.3 %

NYSE UNH opened at $583.58 on Tuesday. The business’s fifty day moving average is $582.24 and its 200-day moving average is $527.84. UnitedHealth Group has a one year low of $436.38 and a one year high of $607.94. The stock has a market capitalization of $537.12 billion, a price-to-earnings ratio of 35.79, a PEG ratio of 1.65 and a beta of 0.58. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.44%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on UNH. Wells Fargo & Company lifted their price objective on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a report on Tuesday, October 1st. UBS Group lifted their target price on UnitedHealth Group from $640.00 to $680.00 and gave the company a “buy” rating in a report on Thursday, July 18th. Jefferies Financial Group raised UnitedHealth Group from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $481.00 to $647.00 in a report on Wednesday, July 17th. Finally, Morgan Stanley boosted their price objective on UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Two equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $614.17.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In related news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.